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Background
DNA methylation is an important epigenetic process that
regulates gene expression mainly through its effect on
chromatin conformation. It involves the stable mainte-
nance of methylated cytosines at CpG dinucleotides
(meCpGs) which in turn can regulate gene expression by
two mechanisms: by direct interference with transcription
factors binding to their target sequences, or by binding
MeCP2 proteins, which recognize methylated DNA and
recruit histone deacetilases, resulting in a highly compact
chromatin structure. Human Papillomavirus (HPV) E2
protein controls various viral processes, including gene
transcription and DNA replication. These activities rely
upon its ability to bind as an homodimer to its target
sequences (5'-ACCGN4CGGT-3') in the viral DNA. Since
these sequences contain CpG dinucleotides, they are
potential targets for DNA methylation, and, in fact, it has
been demonstrated that E2's ability to bind to its cognate
sequence is inhibited by methylation. Different studies
have shown that the methylation patterns of HPV DNA, in
the long control region (LCR) and the 3' region of the L1
gene, are heterogeneous in human cell lines and clinical
samples. The objective of this study was to determine the
methylation status of HPV type 18 and 16 DNA in differ-
ent human-derived cell lines.
Materials and methods
DNA from HeLa, ViPa and CaLo cell lines (with integrated
HPV type 18 DNA) was extracted and modified with
sodium bisulfite. The 5' region of the L1 gene, the com-
plete LCR (divided in three regions) and the 5' region of
the  E6  gene, were amplified using specific primers
designed for modified DNA. These PCR fragments were
cloned in TOPO A vector and 10 clones from each cell line
were sequenced for analysis.
Results
DNA methylation patterns observed in three different cell
lines containing HPV type 18 DNA showed great similar-
ity. No methylation of CpG dinucleotides was observed in
the complete LCR and the 5' region of the E6 gene in CaLo
cell line. Similarly, the enhancer and promoter regions
within the LCR, and the 5' region of E6 were unmethyl-
ated in HeLa and ViPa cell lines. However, the 5' region of
the L1 gene, although mostly hypermethylated in HeLa
and CaLo, exhibited an heterogeneous pattern in ViPa
cells. Interestingly, the CpG at position 7318 (within the
5' region of the LCR) was consistently found methylated
in two cell lines (HeLa and ViPa), as opposed to CaLo
where it was found unmethylated.
Conclusion
The methylation patterns of HPV 18 DNA in these three
cell lines are very similar, with the LCR generally unmeth-
ylated. The heterogeneity of the methylation patterns in
the 5' region of the L1 gene reported in previous studies
was confirmed in the present work. Further studies are
needed in order to determine if these patterns are consist-
ent in tumor samples, and how they correlate with various
stages of the carcinogenic process and the viral life cycle.
from 24th Annual Meeting of the National Cancer Institute of Mexico
Mexico City, Mexico. 14–17 February 2007
Published: 5 February 2007
BMC Cancer 2007, 7(Suppl 1):A26 doi:10.1186/1471-2407-7-S1-A26
<supplement> <title> <p>24<sup>th </sup>Annual Meeting of the National Cancer Institute of Mexico</p> </title> <editor>Alfonso Duenas-Gonzalez, Dolores Gallardo-Rincon, Luis A Herrera, Myrna Candelaria, Adolfo Fuentes-Alburo</editor> <note>Meeting abstracts – A single PDF containing all  abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1471-2407-7-S1-full.pdf">here</a>.</note> </supplement>
This article is available from: http://www.biomedcentral.com/1471-2407/7/S1/A26
© 2007 Méndez et al; licensee BioMed Central Ltd. Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cancer 2007, 7(Suppl 1):A26 http://www.biomedcentral.com/1471-2407/7/S1/A26
Page 2 of 2
(page number not for citation purposes)
Further analysis using methylation-specificand Headloop
suppression PCR will be useful to establish the CpG meth-
ylation patterns of the viral genome in different types of
lesions (low and high grade) and during different stages of
the viral life cycle.